Aclaris 制药 ACRS
$3.90 +$0.29 (+8.03%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $3.90 0.00%
开盘$3.62
昨收$3.61
当日区间$3.61 – $3.98
成交量3.53M
市值$618.59M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例84.1%-1.65 个百分点，较上季度
持仓机构数179+5 ，较上季度
内部人近期交易40次买入 / 10次卖出净买入
空头持仓比例10.21% 占流通股回补天数 3.0 · 截至 15 Oct 2026
卖空成交量占比26.1%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$20.41M（2个净流入日，18个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有35.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从9.86%升至10.21%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +3,804,142 | 5.9% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +249,775 | 0.2% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +5,918,954 | 8.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,629,943 | 6.8% |
| Silverarc Capital Management, LLC | Hedge Fund | 2026/Q3 | +1,946,482 | 1.3% |
| Jones Hill Capital LP | Hedge Fund | 2026/Q3 | +1,759,492 | 1.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,246,594 | 2.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +928,711 | 4.6% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +853,862 | 0.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +766,367 | 2.2% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +650,549 | 0.7% |
| Braidwell LP | Hedge Fund | 2026/Q3 | +443,232 | 1.5% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +421,500 | 0.3% |
| Tetragon Partners UK LLP | Hedge Fund | 2026/Q3 | +400,000 | 0.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +314,900 | 0.6% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 31 Jul 2026 | Roland Kolbeck | Chief Scientific Officer | Derivative Exercise and Sale | -12,385 | $5.20 | 23,990 |
| 31 Jul 2026 | Roland Kolbeck | Chief Scientific Officer | Derivative Exercise and Retained | +23,990 | – | 23,990 |
| 4 Jun 2026 | Vincent Milano | Independent Director | Derivative Exercise and Retained | +11,580 | – | 28,896 |
| 4 Jun 2026 | Andrew Schiff | Independent Director | Derivative Exercise and Retained | +11,580 | – | 25,540 |
| 4 Jun 2026 | Maxine Gowen | Independent Director | Derivative Exercise and Retained | +11,580 | – | 33,334 |
| 4 Jun 2026 | William Humphries | Independent Director | Derivative Exercise and Retained | +11,580 | – | 45,105 |
| 4 Jun 2026 | Anand Mehra | Independent Director | Derivative Exercise and Retained | +11,580 | – | 726,403 |
| 4 Jun 2026 | Christopher Molineaux | Lead Independent Director | Derivative Exercise and Retained | +11,580 | – | 69,536 |
| 3 Jun 2026 | Vincent Milano | Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | Vincent Milano | Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
| 3 Jun 2026 | Andrew Schiff | Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | Andrew Schiff | Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
| 3 Jun 2026 | Maxine Gowen | Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | Maxine Gowen | Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
| 3 Jun 2026 | William Humphries | Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | William Humphries | Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
| 3 Jun 2026 | Anand Mehra | Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | Anand Mehra | Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
| 3 Jun 2026 | Christopher Molineaux | Lead Independent Director | Other Derivative Acquisition | +10,987 | – | 10,987 |
| 3 Jun 2026 | Christopher Molineaux | Lead Independent Director | Other Derivative Acquisition | +42,350 | $4.71 | 42,350 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 15,027,284 | 10.2% | 3.0 |
| 30 Sep 2026 | 18,191,280 | 12.4% | 6.5 |
| 15 Sep 2026 | 16,075,295 | 10.9% | 6.4 |
| 31 Aug 2026 | 15,180,778 | 10.3% | 8.7 |
| 14 Aug 2026 | 14,710,712 | 10.0% | 7.0 |
| 31 Jul 2026 | 13,774,975 | 9.9% | 8.7 |
暂无评论——快来第一个聊聊 ACRS。